Sort
39,280 grants matching “leukemia”
MINORITY BASED COMMUNITY CLINICAL ONCOLOGY PROGRAM
$497,024Mobile Infirmary Medical Center · U10 · FY2002 · CA
Selectively Targeting Oncogenic NRAS in Cancer
$497,010Kevin M Shannon · University Of California, San Francisco · R01 · FY2018 · CA
Selectively Targeting Oncogenic NRAS in Cancer
$497,010Kevin M Shannon · University Of California, San Francisco · R01 · FY2017 · CA
NOVEL IMMUNOTHERAPY OPTIONS FOR PEDIATRIC ACUTE MYELOID LEUKEMIA
$497,000The Nemours Foundation · · FY2022 · Defense Health Agency
Tuning CAR-T cell function
$496,990Gianpietro Dotti · Univ Of North Carolina Chapel Hill · R01 · FY2021 · CA
Restoration of Tumor Suppression Activity in Malignant Melanoma
$496,909David Joseph Weber · University Of Maryland Baltimore · R01 · FY2006 · CA
The cohesin complex as a tumor suppressor in myeloid leukemia
$496,859Iannis Aifantis · New York University School Of Medicine · R01 · FY2020 · CA
Predictors of Adult Leukemia
$496,842Julie Ann Ross · University Of Minnesota · R01 · FY2006 · CA
Therapeutic targeting of glutamine metabolism in MDS
$496,810Marina Y Konopleva · University Of Tx Md Anderson Can Ctr · R01 · FY2018 · CA
Restoration of Tumor Suppression Activity in Malignant Melanoma
$496,770David Joseph Weber · University Of Maryland Baltimore · R01 · FY2010 · CA
Dysregulation of Innate Lymphoid Immunity in Acute Myeloid Leukemia
$496,689Bethany Mundy-Bosse · Ohio State University · R01 · FY2023 · CA
Dual targeting of XPO1 and BTK in B cell malignancies
$496,655Rosa Lapalombella · Ohio State University · R01 · FY2019 · CA
Developing and credentialing patient-derived xenograft models to advance therapeutic approaches for chronic myelomonocytic leukemia
$496,640Eric Padron · H. Lee Moffitt Cancer Ctr & Res Inst · R37 · FY2020 · CA
Developing and credentialing patient-derived xenograft models to advance therapeutic approaches for chronic myelomonocytic leukemia
$496,638Eric Padron · H. Lee Moffitt Cancer Ctr & Res Inst · R37 · FY2022 · CA
Developing and credentialing patient-derived xenograft models to advance therapeutic approaches for chronic myelomonocytic leukemia
$496,638Eric Padron · H. Lee Moffitt Cancer Ctr & Res Inst · R37 · FY2021 · CA
Administrative Core
$496,614Karen R Rabin · Baylor College Of Medicine · P20 · FY2023 · CA
Identification of small molecule modulators of mitochondrial creatine kinase 1
$496,612Eduard A. Sergienko · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2021 · CA
CAREER: A Data-Driven Network Inference Framework for Context-Conditioned Protein Interaction Graphs
$496,556Yanjun Qi · University Of Virginia Main Campus · · FY2015 · CSE
MOLECULAR PATHOLOGY OF LYMPHOID MALIGNANCIES
$496,511Stanford University · R37 · FY2002 · CA
LIFR-alpha/JAK/STAT3-dependent Adipose Inflammation Contributes to Obesity-Associated NAFLD - Resubmissi
$496,510Rodney E Infante · Ut Southwestern Medical Center · R01 · FY2024 · DK
FANCD2 interaction with mismatch repair proteins and MCM2-7
$496,500Gary M. Kupfer · Yale University · R01 · FY2012 · HL
Project 2: Defining the Role of Megakaryocyte Abnormalities in the Progression of Primary Myelofibrosis
$496,500John D Crispino · Icahn School Of Medicine At Mount Sinai · P01 · FY2023 · CA
FANCD2 interaction with mismatch repair proteins and MCM2-7
$496,500Gary M. Kupfer · Yale University · R01 · FY2011 · HL
Mitochondrial NAD+ in Acute Myeloid Leukemias
$496,412Xiaolu Ang Cambronne · University Of Texas At Austin · R01 · FY2024 · CA
PHASE II/III CLINICAL TRIALS OF ANTICANCER AGENTS
$496,374University Of Texas Md Anderson Can Ctr · U01 · FY2000 · CA